美康基因 (834367.OC)

+ 收藏

现金流量表(美康基因)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 17,483,796.0641,613,653.9120,659,588.9048,432,969.0322,189,566.52
 收到其他与经营活动有关的现金(元) 572,576.403,111,958.711,794,596.631,066,784.862,422,933.26
 经营活动现金流入小计(元) 18,056,372.4644,725,612.6222,454,185.5349,499,753.8924,612,499.78
 购买商品、接受劳务支付的现金(元) 3,580,925.799,103,856.835,914,685.0612,888,704.726,048,424.43
 支付给职工以及为职工支付的现金(元) 8,582,562.1016,106,109.197,663,760.8019,509,623.758,745,223.22
 支付的各项税费(元) 1,090,245.462,204,212.361,399,279.781,283,838.46344,202.61
 支付其他与经营活动有关的现金(元) 5,845,146.8616,008,007.348,585,581.5411,344,325.327,681,563.57
 经营活动现金流出小计(元) 19,098,880.2143,422,185.7223,563,307.1845,026,492.2522,819,413.83
 经营活动产生的现金流量净额(元) -1,042,507.751,303,426.90-1,109,121.654,473,261.641,793,085.95
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) ---2,980.97-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -300.00300.001,300.00-
 收到其他与投资活动有关的现金(元) ---1,005,157.87-
 投资活动现金流入小计(元) -300.00300.001,009,438.84-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 923,152.622,174,657.871,443,839.69613,963.37290,951.70
 投资支付的现金(元) ---360,000.00-
 支付其他与投资活动有关的现金(元) ---1,000,000.00-
 投资活动现金流出小计(元) 923,152.622,174,657.871,443,839.691,973,963.37290,951.70
 投资活动产生的现金流量净额(元) -923,152.62-2,174,357.87-1,443,539.69-964,524.53-290,951.70
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) -100,000.00---
  其中:子公司吸收少数股东投资收到的现金(元) -100,000.00---
 取得借款收到的现金(元) 20,544,900.0029,300,000.0026,200,000.0016,550,000.007,000,000.00
 收到其他与筹资活动有关的现金(元) ---3,000,000.00-
 筹资活动现金流入小计(元) 20,544,900.0029,400,000.0026,200,000.0019,550,000.007,000,000.00
 偿还债务支付的现金(元) 17,100,000.0026,900,000.0024,700,000.0017,698,000.008,948,000.00
 分配股利、利润或偿付利息支付的现金(元) 213,274.56323,265.73136,131.55555,762.54246,842.36
 支付其他与筹资活动有关的现金(元) 1,951,497.883,849,728.62812,968.004,013,681.47383,765.20
 筹资活动现金流出小计(元) 19,264,772.4431,072,994.3525,649,099.5522,267,444.019,578,607.56
 筹资活动产生的现金流量净额(元) 1,280,127.56-1,672,994.35550,900.45-2,717,444.01-2,578,607.56
四、汇率变动对现金及现金等价物的影响(元) --134.94-57,120.6429,772.75
五、现金及现金等价物净增加额(元) -685,532.81-2,544,060.26-2,001,760.89848,413.74-1,046,700.56
 加:期初现金及现金等价物余额(元) 1,359,796.653,903,856.913,903,856.913,055,443.173,055,443.17
 期末现金及现金等价物余额(元) 674,263.841,359,796.651,902,096.023,903,856.912,008,742.61
补充资料:
 净利润(元) -2,868,894.78-5,750,366.74-1,168,567.42-4,354,374.84-4,183,454.88
 固定资产和投资性房地产折旧(元) 1,078,249.913,604,976.791,787,919.143,873,747.032,047,126.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,078,249.913,604,976.791,787,919.143,873,747.032,047,126.53
 无形资产摊销(元) 1,239,028.782,956,530.161,466,275.372,953,112.231,363,544.57
 长期待摊费用摊销(元) 614,761.951,953,727.661,110,149.862,843,140.55895,605.05
 处置固定资产、无形资产和其他长期资产的损失(元) ---43,219.69-
 固定资产报废损失(元) -10,301.46-26,023.69-
 财务费用(元) -452,004.33209,192.44851,911.40251,309.43
 投资损失(元) ---263,253.15204,150.47
 递延所得税(元) -16,948.50---
  其中:递延所得税资产减少(元) -458,430.05---
 递延所得税负债增加(元) --441,481.55---
 存货的减少(元) 935,409.25-1,484,080.12-556,026.04-527,355.56876,034.44
 经营性应收项目的减少(元) 284,643.41-4,145,110.55-834,698.952,050,876.03269,733.29
 经营性应付项目的增加(元) -1,023,283.65-1,167,586.40-4,581,716.42-6,983,132.85-1,421,356.29
 其他(元) -2,924,215.06----
 现金的期末余额(元) 674,263.841,359,796.651,902,096.023,903,856.912,008,742.61
 减:现金的期初余额(元) 1,359,796.653,903,856.913,903,856.913,055,443.173,055,443.17
 现金及现金等价物的净增加额(元) -685,532.81-2,544,060.26-2,001,760.89848,413.74-1,046,700.56
公告日期 2024-08-282024-04-232023-08-292023-04-182022-08-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院